FDA Inspection 885328 — Hikma Pharmaceuticals USA INC.

Hikma Pharmaceuticals USA INC. — FEI 1510690

The FDA completed an inspection of Hikma Pharmaceuticals USA INC. on Jun 26, 2014 in Columbus, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 26, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Columbus, OH (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
683321 CFR 314.80(c)(2)(ii)(A)Incomplete periodic safety report
890821 CFR 314.81(b)(2)(i)Summary

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.